NASDAQ | TSX: ACB
Newly created directorship to be filled
by Rajesh Uttamchandani
EDMONTON, AB, May 15, 2024 /CNW/ - Aurora Cannabis Inc.
(the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB),
the Canadian based leading global medical cannabis company,
announced today the appointment of Rajesh Uttamchandani
to the Company's Board of Directors (the
"Board"), effective today.
Mr. Uttamchandani joins the Board with notable expertise in
strategy development, innovation, human capital and governance. His
impressive career is characterized by executive level roles with
leading businesses in emerging technology, FinTech, human capital
consulting and global education. Most recently, he was the Chief
People Officer for ApplyBoard, an organization recognized as one of
the fastest-growing technology companies in Canada. Previous roles include serving as
Chief Operating Officer and Chief People Officer at MaRs Discovery
District, North America's largest
urban innovation hub committed to advancing companies during their
prime periods of growth and Chief Human Resources Officer and
Managing Director at Zafin, a Global FinTech supporting
modernization of the world's Tier-1 banks.
"I am very pleased to be welcoming Raj to our Board of
Directors. He brings a breadth of knowledge and capability from a
variety of sectors and disciplines that will undoubtedly be
additive to Aurora and complement the existing strength of our
Board. As we pursue our objective to achieve sustainable
performance and global leadership in the cannabis market, we will
benefit from Raj's experience in human capital, strategy and
innovation – all of which are woven into our strategic priorities –
as well as from his past and current directorships," said
Ron Funk, Chairman of Aurora
Cannabis.
Mr. Uttamchandani brings to Aurora a wealth of experience as
current and past Director for private and public organizations,
including LifeSpeak, Ontario Cannabis Stores, Mackenzie Health, and
several not-for-profit organizations. Mr. Uttamchandani holds
several degrees and professional designations, including a Master
of Industrial Relations and Human Resources from University of Toronto; a Juris Doctor from Osgoode
Hall Law School; and an L.L.M in Employment and Labour, also from
Osgoode Hall Law School. He is a holder of the Institute of
Corporate Directors Director designation (ICD.D) and is a lawyer
called to the Bar of Ontario.
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both the
medical and consumer markets
across Canada, Europe, Australia and South America. Headquartered
in Edmonton, Alberta, Aurora is a
pioneer in global cannabis, dedicated to helping people improve
their lives. The Company's adult- use brand portfolio includes
Aurora Drift, San Rafael '71, Daily Special, Tasty's, Being and
Greybeard. Medical cannabis brands include MedReleaf, CanniMed,
Aurora and Whistler Medical Marijuana Co, as well as international
brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a
controlling interest in Bevo Farms Ltd., North America's leading
supplier of propagated agricultural plants. Driven by science and
innovation, and with a focus on high-quality cannabis products,
Aurora's brands continue to break through as industry leaders in
the medical, wellness and adult recreational markets wherever they
are launched. Learn more at www.auroramj.com and follow us
on X and LinkedIn.
Forward-looking Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements").
Forward-looking statements are frequently characterized by words
such as "plan", "continue", "expect", "project", "intend",
"believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain
events or conditions "may" or "will" occur. Forward-looking
statements made in this news release include, but are not limited
to, statements regarding the appointment of a new director to the
Company's Board of Directors and associated benefits, and the
Company's plans to achieve sustainable performance and global
leadership in the cannabis market.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions management considers to be
reasonable. Material factors or assumptions involved in developing
forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from
market research and industry analysis and on assumptions based on
data and knowledge of this industry which the Company believes to
be reasonable. Forward-looking statements are subject to a variety
of risks, uncertainties and other factors that management believes
to be relevant and reasonable in the circumstances could cause
actual events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements. These risks include,
but are not limited to, the ability to retain key personnel, the
ability to continue investing in infrastructure to support growth,
the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the
development of third party government and non-government consumer
sales channels, management's estimates of consumer demand in
Canada and in jurisdictions where
the Company exports, expectations of future results and expenses,
the risk of successful integration of acquired business and
operations (with respect to the Transaction and more generally with
respect to future acquisitions), management's estimation that
SG&A will grow only in proportion of revenue growth, the
ability to expand and maintain distribution capabilities, the
impact of competition, the general impact of financial market
conditions, the yield from cannabis growing operations, product
demand, changes in prices of required commodities, competition, and
the possibility for changes in laws, rules, and regulations in the
industry, epidemics, pandemics or other public health crises,
including the current outbreak of COVID-19, and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information from dated June 14, 2023 (the "AIF") and filed with Canadian
securities regulators available on the Company's issuer profile on
SEDAR+ at www.sedarplus.com and filed with and available on the
SEC's website at www.sec.gov. The Company cautions that the list of
risks, uncertainties and other factors described in the AIF is not
exhaustive and other factors could also adversely affect its
results. Readers are urged to consider the risks, uncertainties and
assumptions carefully in evaluating the forward-looking statements
and are cautioned not to place undue reliance on such information.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable securities
law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-announces-appointment-of-new-director-302145765.html
SOURCE Aurora Cannabis Inc.